Ignite Creation Date:
2025-12-25 @ 2:40 AM
Ignite Modification Date:
2025-12-27 @ 10:55 PM
Study NCT ID:
NCT00959933
Status:
COMPLETED
Last Update Posted:
2017-03-28
First Post:
2009-08-13
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Relative Bioavailability Study of Ribavirin 200 Capsules and Rebetol 200 mg Capsules in Females Under Non-Fasting Conditions
Sponsor:
Sandoz
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2001-04
Start Date Type:
None
Primary Completion Date:
2001-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2001-05
Completion Date Type:
ACTUAL
First Submit Date:
2009-08-13
First Submit QC Date:
None
Study First Post Date:
2009-08-17
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-03-27
Last Update Post Date:
2017-03-28
Last Update Post Date Type:
ACTUAL